A randomized controlled pilot study of add-on therapy of CIM-MEG19 (standardized Andrographis paniculata formulation) in mild to moderate COVID-19.

ABSTRACT:

Background

Traditional knowledge and scientific shreds of evidence strongly support the repurpose of Kalmegh (Andrographis paniculata, CIM-MEG19) as an alternate therapy for prophylactic management and treatment of severe acute respiratory syndrome coronavirus (SARS-CoV) and associated health disorders.

Purpose

The study aimed to assess the efficacy and safety of the CIM-MEG19 (standardized A. paniculata extract formulation), a proprietary Ayurvedic medicine in the COVID-19 management, clinical recovery, and outcomes in terms of hospitalization days as well as any sign of severity due to drug-drug interaction between CIM-MEG19 ^TM and standard of care (SoC).

Methods

A randomized, parallel-group, active-controlled interventional pilot cli

SUBMITTER: Shanker K 

PROVIDER: S-EPMC9762910 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature